{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:36:12Z","timestamp":1790231772071,"version":"4.1.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19bm0104001"],"award-info":[{"award-number":["JP19bm0104001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19bm0104001"],"award-info":[{"award-number":["JP19bm0104001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19bk0104003h"],"award-info":[{"award-number":["JP19bk0104003h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19bm0404037"],"award-info":[{"award-number":["JP19bm0404037"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19bm0404037"],"award-info":[{"award-number":["JP19bm0404037"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["18H04164"],"award-info":[{"award-number":["18H04164"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00018-020-03749-8","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T02:14:48Z","timestamp":1610590488000},"page":"3385-3401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Generation and manipulation of human iPSC-derived platelets"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-9175","authenticated-orcid":false,"given":"Naoshi","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"4","key":"3749_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"issue":"5","key":"3749_CR2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861\u2013872","journal-title":"Cell"},{"issue":"5858","key":"3749_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917\u20131920. https:\/\/doi.org\/10.1126\/science.1151526","journal-title":"Science"},{"issue":"7175","key":"3749_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141\u2013146. https:\/\/doi.org\/10.1038\/nature06534","journal-title":"Nature"},{"key":"3749_CR5","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1242\/dev.138172","volume":"143","author":"P Karagiannis","year":"2016","unstructured":"Karagiannis P, Eto K (2016) Ten years of induced pluripotency: from basic mechanisms to therapeutic applications. Development 143:2039\u20132043","journal-title":"Development"},{"issue":"18","key":"3749_CR6","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra1716145","volume":"380","author":"HM Blau","year":"2019","unstructured":"Blau HM, Daley GQ (2019) Stem cells in the treatment of disease. N Engl J Med 380(18):1748\u20131760","journal-title":"N Engl J Med"},{"issue":"5","key":"3749_CR7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H et al (2008) Disease-specific induced pluripotent stem cells. Cell 134(5):877\u2013886","journal-title":"Cell"},{"key":"3749_CR8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3389\/fimmu.2018.02243","volume":"9","author":"H Kim","year":"2018","unstructured":"Kim H, Schaniel C (2018) Modeling hematological diseases and cancer with patient-specific induced pluripotent stem cells. Front Immunol 9:2243","journal-title":"Front Immunol"},{"key":"3749_CR9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/asheducation-2013.1.638","volume":"2013","author":"ZM Szczepiorkowski","year":"2013","unstructured":"Szczepiorkowski ZM, Dunbar NM (2013) Transfusion guidelines: when to transfuse. Hematol Am Soc Hematol Educ Program 2013:638\u2013644","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3749_CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","volume":"176","author":"LJ Estcourt","year":"2017","unstructured":"Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, Mumford AD, Stanworth SJ, Tinegate H (2017) Guidelines for the use of platelet transfusions. Br J Haematol 176:365\u2013394","journal-title":"Br J Haematol"},{"key":"3749_CR11","volume-title":"The 2011 National Blood Collection and Utilization Survey Report","author":"BI Whitaker","year":"2011","unstructured":"Whitaker BI, Hinkins S (2011) The 2011 National Blood Collection and Utilization Survey Report. The United States Department of Health and Human Services, Washington"},{"key":"3749_CR12","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(13)60631-5","volume":"381","author":"LM Williamson","year":"2013","unstructured":"Williamson LM, Devine DV (2013) Challenges in the management of the blood supply. Lancet 381:1866\u20131875","journal-title":"Lancet"},{"issue":"20","key":"3749_CR13","doi-asserted-by":"publisher","first-page":"30186","DOI":"10.1016\/S2352-3026(20)30186-1","volume":"S2352\u20133026","author":"SJ Stanworth","year":"2020","unstructured":"Stanworth SJ, New HV, Apelseth TO et al (2020) Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol S2352\u20133026(20):30186\u201330191. https:\/\/doi.org\/10.1016\/S2352-3026(20)30186-1","journal-title":"Lancet Haematol"},{"issue":"3","key":"3749_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","volume":"171","author":"SJ Stanworth","year":"2015","unstructured":"Stanworth SJ, Navarrete C, Estcourt L, Marsh J (2015) Platelet refractoriness\u2013practical approaches and ongoing dilemmas in patient management. Br J Haematol 171(3):297\u2013305","journal-title":"Br J Haematol"},{"key":"3749_CR15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tmrv.2017.05.002","volume":"312","author":"P Kiely","year":"2017","unstructured":"Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM (2017) Emerging infectious diseases and blood safety: modeling the transfusion-transmission risk. Transfus Med. 312:154\u2013164","journal-title":"Transfus Med."},{"key":"3749_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-bioeng-071813-104950","volume":"16","author":"AF Palmer","year":"2014","unstructured":"Palmer AF, Intaglietta M (2014) Blood substitutes. Annu Rev Biomed Eng 16:77\u2013101","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"3749_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/trf.15543","volume":"60","author":"A Girish","year":"2020","unstructured":"Girish A, Sekhon U, Sen GA (2020) Bioinspired artificial platelets for transfusion applications in traumatic hemorrhage. Transfusion 60(2):229\u2013231","journal-title":"Transfusion"},{"issue":"10","key":"3749_CR18","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1111\/trf.15427","volume":"59","author":"K Hagisawa","year":"2019","unstructured":"Hagisawa K, Kinoshita M, Takikawa M, Takeoka S, Saitoh D, Seki S, Sakai H (2019) Combination therapy using fibrinogen \u03b3-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits. Transfusion 59(10):3186\u20133196","journal-title":"Transfusion"},{"issue":"1","key":"3749_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/11530740-000000000-00000","volume":"9","author":"RW Toner","year":"2011","unstructured":"Toner RW, Pizzi L, Leas B, Ballas SK, Quigley A, Goldfarb NI (2011) Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy 9(1):29\u201337","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"3749_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/MCB.13.1.473","volume":"13","author":"G Keller Keller","year":"1993","unstructured":"Keller Keller G, Kennedy M, Papayannopoulou T, Wiles MV (1993) Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 13(1):473\u2013486","journal-title":"Mol Cell Biol"},{"issue":"5175","key":"3749_CR21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.8066449","volume":"265","author":"T Nakano","year":"1994","unstructured":"Nakano T, Kodama H, Honjo T (1994) Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265(5175):1098\u20131101","journal-title":"Science"},{"issue":"16","key":"3749_CR22","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.1073\/pnas.92.16.7530","volume":"92","author":"R Palacios","year":"1995","unstructured":"Palacios R, Golunski E, Samaridis J (1995) In vitro generation of hematopoietic stem cells from an embryonic stem cell line. Proc Natl Acad Sci U S A 92(16):7530\u20137534","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3749_CR23","doi-asserted-by":"crossref","first-page":"10716","DOI":"10.1073\/pnas.191362598","volume":"98","author":"DS Kaufman","year":"2001","unstructured":"Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716\u201310721","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"3749_CR24","doi-asserted-by":"crossref","first-page":"12819","DOI":"10.1073\/pnas.202380099","volume":"99","author":"K Eto","year":"2002","unstructured":"Eto K, Murphy R, Kerrigan SW et al (2002) Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci USA 99(20):12819\u201312824","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"3749_CR25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2005-03-0987","volume":"106","author":"ES Ng","year":"2005","unstructured":"Ng ES, Davis RP, Azzola L, Stanley EG, Elefanty AG (2005) Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 106(5):1601\u20131603","journal-title":"Blood"},{"issue":"8","key":"3749_CR26","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.4049\/jimmunol.175.8.5095","volume":"175","author":"PS Woll","year":"2005","unstructured":"Woll PS, Martin CH, Miller JS, Kaufman DS (2005) Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 175(8):5095\u20135103","journal-title":"J Immunol"},{"issue":"2","key":"3749_CR27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1538-7836.2006.01744.x","volume":"4","author":"M Gaur","year":"2006","unstructured":"Gaur M, Kamata T, Wang S, Moran B, Shattil SJ, Leavitt AD (2006) Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost 4(2):436\u2013442","journal-title":"J Thromb Haemost"},{"issue":"9","key":"3749_CR28","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1172\/JCI38591","volume":"119","author":"KD Choi","year":"2009","unstructured":"Choi KD, Vodyanik MA, Slukvin II (2009) Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 119(9):2818\u20132829","journal-title":"J Clin Invest"},{"issue":"27","key":"3749_CR29","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2009-04-217406","volume":"114","author":"Z Ye","year":"2009","unstructured":"Ye Z, Zhan H, Mali P et al (2009) Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114(27):5473\u20135480","journal-title":"Blood"},{"issue":"13","key":"3749_CR30","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1084\/jem.20100844","volume":"207","author":"N Takayama","year":"2010","unstructured":"Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H et al (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207(13):2817\u20132830","journal-title":"J Exp Med"},{"issue":"14","key":"3749_CR31","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2009-07-234690","volume":"115","author":"AE Grigoriadis","year":"2010","unstructured":"Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH et al (2010) Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115(14):2769\u20132776","journal-title":"Blood"},{"issue":"9","key":"3749_CR32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/gt.2011.22","volume":"18","author":"S Senju","year":"2011","unstructured":"Senju S, Haruta M, Matsumura K, Matsunaga Y, Fukushima S, Ikeda T et al (2011) Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy. Gene Ther 18(9):874\u2013883","journal-title":"Gene Ther"},{"issue":"1","key":"3749_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm.2016.127","volume":"18","author":"A Ditadi","year":"2017","unstructured":"Ditadi A, Sturgeon CM, Keller G (2017) A view of human haematopoietic development from the Petri dish. Nat Rev Mol Cell Biol 18(1):56\u201367","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"3749_CR34","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/1873-3468.12459","volume":"590","author":"J Palis","year":"2016","unstructured":"Palis J (2016) Hematopoietic stem cell-independent hematopoiesis: emergence of erythroid, megakaryocyte, and myeloid potential in the mammalian embryo. FEBS Lett 590(22):3965\u20133974","journal-title":"FEBS Lett"},{"issue":"13","key":"3749_CR35","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2018-11-835371","volume":"133","author":"B Psaila","year":"2019","unstructured":"Psaila B, Mead AJ (2019) Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation. Blood 133(13):1427\u20131435","journal-title":"Blood"},{"issue":"1","key":"3749_CR36","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/s41467-018-04441-z","volume":"9","author":"K Sumide","year":"2018","unstructured":"Sumide K, Matsuoka Y, Kawamura H, Nakatsuka R, Fujioka T, Asano H, Takihara Y, Sonoda Y (2018) A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. Nat Commun 9(1):2202","journal-title":"Nat Commun"},{"issue":"121","key":"3749_CR37","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2012-06-434407","volume":"2013","author":"G Amabile","year":"2013","unstructured":"Amabile G, Welner RS, Nombela-Arrieta C, D\u2019Alise AM, Di Ruscio A, Ebralidze AK, Kraytsberg Y, Ye M, Kocher O, Neuberg DS et al (2013) In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 2013(121):1255\u20131264","journal-title":"Blood"},{"issue":"21","key":"3749_CR38","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/mt.2013.71","volume":"2013","author":"N Suzuki","year":"2013","unstructured":"Suzuki N, Yamazaki S, Yamaguchi T, Okabe M, Masaki H, Takaki S, Otsu M, Nakauchi H (2013) Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 2013(21):1424\u20131431","journal-title":"Mol Ther"},{"key":"3749_CR39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature22370","volume":"545","author":"R Sugimura","year":"2017","unstructured":"Sugimura R, Jha DK, Han A, Soria-Valles C, da Rocha EL, Lu Y-F, Goettel JA, Serrao E, Rowe RG, Malleshaiah M et al (2017) Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545:432\u2013438","journal-title":"Nature"},{"issue":"1","key":"3749_CR40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41467-019-08705-0","volume":"10","author":"M Lopez-Yrigoyen","year":"2019","unstructured":"Lopez-Yrigoyen M, Yang CT, Fidanza A et al (2019) Genetic programming of macrophages generates an in vitro model for the human erythroid island niche. Nat Commun 10(1):881","journal-title":"Nat Commun"},{"issue":"15","key":"3749_CR41","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/bloodadvances.2018020560","volume":"2","author":"K Vanuytsel","year":"2018","unstructured":"Vanuytsel K, Matte T, Leung A et al (2018) Induced pluripotent stem cell-based mapping of \u03b2-globin expression throughout human erythropoietic development. Blood Adv 2(15):1998\u20132011","journal-title":"Blood Adv"},{"key":"3749_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/5584_2018_228","volume":"1107","author":"S Demirci","year":"2018","unstructured":"Demirci S, Tisdale JF (2018) Definitive Erythropoiesis from Pluripotent Stem Cells: Recent Advances and Perspectives. Adv Exp Med Biol 1107:1\u201313","journal-title":"Adv Exp Med Biol"},{"key":"3749_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2018.02.003","volume":"61","author":"KE Elagib","year":"2018","unstructured":"Elagib KE, Brock AT, Goldfarb AN (2018) Megakaryocyte ontogeny: Clinical and molecular significance. Exp Hematol 61:1\u20139","journal-title":"Exp Hematol"},{"issue":"4","key":"3749_CR44","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/bloodadvances.2018024372","volume":"3","author":"A Margraf","year":"2019","unstructured":"Margraf A, Nussbaum C, Sperandio M (2019) Ontogeny of platelet function. Blood Adv 3(4):692\u2013703","journal-title":"Blood Adv"},{"key":"3749_CR45","doi-asserted-by":"crossref","unstructured":"Liu ZJ, Hoffmeister KM, Hu Z, Mager DE, Ait-Oudhia S, De- brincat MA, Pleines I, Josefsson EC, Kile BT, Italiano J Jr, Ramsey H, Grozovsky R, Veng-Pedersen P, Chavda C, Sola-Visner M. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. Blood 2014; 123: 3381\u20139.","DOI":"10.1182\/blood-2013-06-508200"},{"issue":"6","key":"3749_CR46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","volume":"201","author":"KR Machlus","year":"2013","unstructured":"Machlus KR, Italiano JE Jr (2013) The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol 201(6):785\u2013796","journal-title":"J Cell Biol"},{"issue":"5845","key":"3749_CR47","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1126\/science.1146304","volume":"317","author":"T Junt","year":"2007","unstructured":"Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A et al (2007) Dynamic visualization of thrombopoiesis within bone marrow. Science 317(5845):1767\u20131770","journal-title":"Science"},{"issue":"5","key":"3749_CR48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12015-017-9747-z","volume":"13","author":"I Borges","year":"2017","unstructured":"Borges I, Sena I, Azevedo P, Andreotti J, Almeida V, Paiva A, Santos G, Guerra D, Prazeres P, Mesquita LL, Silva LSB, Leonel C, Mintz A, Birbrair A (2017) Lung as a niche for hematopoietic progenitors. Stem Cell Rev Rep 13(5):567\u2013574","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"3749_CR49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2257.2002.00375.x","volume":"24","author":"G Aliberti","year":"2002","unstructured":"Aliberti G, Proietta M, Pulignano I, Tritapepe L, Di Giovanni C, Schiappoli A, Vercillo G (2002) The lungs and platelet production. Clin Lab Haematol 24(3):161\u2013164","journal-title":"Clin Lab Haematol"},{"issue":"7648","key":"3749_CR50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","volume":"544","author":"E Lefrancais","year":"2017","unstructured":"Lefrancais E, Ortiz-Munoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM et al (2017) The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544(7648):105\u2013109","journal-title":"Nature"},{"issue":"3","key":"3749_CR51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.201410052","volume":"209","author":"S Nishimura","year":"2015","unstructured":"Nishimura S, Nagasaki M, Kunishima S, Sawaguchi A, Sakata A, Sakaguchi H et al (2015) IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 209(3):453\u2013466","journal-title":"J Cell Biol"},{"issue":"35","key":"3749_CR52","doi-asserted-by":"crossref","first-page":"E8228","DOI":"10.1073\/pnas.1807000115","volume":"115","author":"T Kanaji","year":"2018","unstructured":"Kanaji T, Vo MN, Kanaji S, Zarpellon A, Shapiro R, Morodomi Y, Yuzuriha A, Eto K, Belani R, Do MH, Yang XL, Ruggeri ZM, Schimmel P (2018) Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia. Proc Natl Acad Sci USA 115(35):E8228\u2013E8235","journal-title":"Proc Natl Acad Sci USA"},{"key":"3749_CR53","unstructured":"Kuter DJ. Megakaryocyte biology and the production of platelets. UpToDate. Waltham, MA: UpToDate Inc.\u00a0https:\/\/www.uptodate.com\u00a0(Accessed on June 11, 2019.)"},{"key":"3749_CR54","volume-title":"Platelets","author":"A Michelson","year":"2019","unstructured":"Michelson A, Cattaneo M, Frelinger A, Newman P (2019) Platelets, 4th edn. Academic Press, Cambridge","edition":"4"},{"key":"3749_CR55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/369565a0","volume":"369","author":"S Lok","year":"1994","unstructured":"Lok S, Kaushansky K, Holly RD et al (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565\u2013568","journal-title":"Nature"},{"key":"3749_CR56","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/369568a0","volume":"369","author":"K Kaushansky","year":"1994","unstructured":"Kaushansky K, Lok S, Holly RD et al (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568\u2013571","journal-title":"Nature"},{"key":"3749_CR57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/369533a0","volume":"369","author":"FJ de Sauvage","year":"1994","unstructured":"de Sauvage FJ, Hass PE, Spencer SD et al (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533\u2013538","journal-title":"Nature"},{"key":"3749_CR58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/369571a0","volume":"369","author":"F Wendling","year":"1994","unstructured":"Wendling F, Maraskovsky E, Debili N et al (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571\u2013574","journal-title":"Nature"},{"issue":"2","key":"3749_CR59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood.V85.2.402.402","volume":"85","author":"ES Choi","year":"1995","unstructured":"Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P (1995) Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85(2):402\u2013413","journal-title":"Blood"},{"issue":"12","key":"3749_CR60","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1634\/stemcells.2006-0309","volume":"24","author":"T Matsunaga","year":"2006","unstructured":"Matsunaga T, Tanaka I, Kobune M, Kawano Y, Tanaka M, Kuribayashi K, Iyama S, Sato T, Sato Y, Takimoto R, Takayama T, Kato J, Ninomiya T, Hamada H, Niitsu Y (2006) Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 24(12):2877\u20132887","journal-title":"Stem Cells"},{"issue":"1","key":"3749_CR61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/vox.12863","volume":"115","author":"I Marini","year":"2020","unstructured":"Marini I, Rigoni F, Zlamal J, Pelzl L, Althaus K, Nowak-Harnau S, Rondina MT, Bakchoul T (2020) Blood donor-derived buffy coat to produce platelets in vitro. Vox Sang 115(1):94\u2013102","journal-title":"Vox Sang"},{"key":"3749_CR62","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","volume":"125","author":"CJ Eaves","year":"2015","unstructured":"Eaves CJ (2015) Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125:2605\u20132613","journal-title":"Blood"},{"key":"3749_CR63","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.molmed.2017.07.003","volume":"23","author":"S Kumar","year":"2017","unstructured":"Kumar S, Geiger H (2017) HSC niche biology and HSC expansion ex vivo. Trends Mol Med 23:799\u2013819","journal-title":"Trends Mol Med"},{"issue":"12","key":"3749_CR64","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1182\/blood-2003-06-1773","volume":"102","author":"TT Fujimoto","year":"2003","unstructured":"Fujimoto TT, Kohata S, Suzuki H, Miyazaki H, Fujimura K (2003) Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood 102(12):4044\u20134051","journal-title":"Blood"},{"issue":"1","key":"3749_CR65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2004.06.006","volume":"21","author":"L Wang","year":"2004","unstructured":"Wang L, Li L, Shojaei F, Levac K, Cerdan C, Menendez P, Martin T, Rouleau A, Bhatia M (2004) Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21(1):31\u201341","journal-title":"Immunity"},{"issue":"11","key":"3749_CR66","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1182\/blood-2007-10-117622","volume":"111","author":"N Takayama","year":"2008","unstructured":"Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T et al (2008) Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111(11):5298\u20135306","journal-title":"Blood"},{"issue":"8","key":"3749_CR67","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2008-09-178863","volume":"114","author":"O Klimchenko","year":"2009","unstructured":"Klimchenko O, Mori M, Distefano A, Langlois T, Larbret F, Lecluse Y, Feraud O, Vainchenker W, Norol F, Debili N (2009) A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 114(8):1506\u20131517","journal-title":"Blood"},{"key":"3749_CR68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/cr.2011.8","volume":"21","author":"SJ Lu","year":"2011","unstructured":"Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, Thon JN, Wang W, Italiano JE, Cho J, Lanza R (2011) Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 21:530\u2013545","journal-title":"Cell Res"},{"key":"3749_CR69","doi-asserted-by":"crossref","first-page":"e55530","DOI":"10.1371\/journal.pone.0055530","volume":"8","author":"M Pick","year":"2013","unstructured":"Pick M, Azzola L, Osborne E, Stanley EG, Elefanty AG (2013) Generation of megakaryocytic progenitors from human embryonic stem cells in a feeder- and serum-free medium. PLoS ONE 8:e55530","journal-title":"PLoS ONE"},{"issue":"5","key":"3749_CR70","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.stemcr.2014.09.010","volume":"3","author":"Q Feng","year":"2014","unstructured":"Feng Q, Shabrani N, Thon JN, Huo H, Thiel A, Machlus KR et al (2014) Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Rep 3(5):817\u2013831","journal-title":"Stem Cell Rep"},{"key":"3749_CR71","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1038\/ncomms11208","volume":"7","author":"T Moreau","year":"2016","unstructured":"Moreau T, Evans AL, Vasquez L, Tijssen MR, Yan Y, Trotter MW et al (2016) Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun 7:11208","journal-title":"Nat Commun"},{"issue":"4","key":"3749_CR72","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2014.01.011","volume":"14","author":"S Nakamura","year":"2014","unstructured":"Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K et al (2014) Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 14(4):535\u2013548","journal-title":"Cell Stem Cell"},{"key":"3749_CR73","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2018.06.011","volume":"174","author":"Y Ito","year":"2018","unstructured":"Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M et al (2018) Turbulence activates platelet biogenesis to enable clinical scale ex vivo production. Cell 174:636\u2013648","journal-title":"Cell"},{"issue":"2","key":"3749_CR74","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/btpr.2595","volume":"34","author":"RW Nurhayati","year":"2018","unstructured":"Nurhayati RW, Ojima Y, Dohda T, Kino-Oka M (2018) Large-scale culture of a megakaryocytic progenitor cell line with a single-use bioreactor system. Biotechnol Prog 34(2):362\u2013369","journal-title":"Biotechnol Prog"},{"issue":"18","key":"3749_CR75","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2012-02-413617","volume":"120","author":"Y Ono","year":"2012","unstructured":"Ono Y, Wang Y, Suzuki H et al (2012) Induction of functional platelets from mouse and human fibroblasts by p45NF-E2\/Maf. Blood 120(18):3812\u20133821","journal-title":"Blood"},{"issue":"3","key":"3749_CR76","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.celrep.2016.09.036","volume":"17","author":"J Pulecio","year":"2016","unstructured":"Pulecio J, Alejo-Valle O, Capellera-Garcia S et al (2016) Direct conversion of fibroblasts to megakaryocyte progenitors. Cell Rep 17(3):671\u2013683","journal-title":"Cell Rep"},{"issue":"7","key":"3749_CR77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood-2018-04-842641","volume":"133","author":"K Tozawa","year":"2019","unstructured":"Tozawa K, Ono-Uruga Y, Yazawa M et al (2019) Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line. Blood 133(7):633\u2013643","journal-title":"Blood"},{"issue":"12","key":"3749_CR78","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1111\/trf.15546","volume":"59","author":"A Patel","year":"2019","unstructured":"Patel A, Clementelli CM, Jarocha D et al (2019) Pre-clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice. Transfusion 59(12):3698\u20133713","journal-title":"Transfusion"},{"key":"3749_CR79","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","volume":"98","author":"J Li","year":"2001","unstructured":"Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M et al (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98:3241\u20133248","journal-title":"Blood"},{"key":"3749_CR80","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","volume":"99","author":"RL Basser","year":"2002","unstructured":"Basser RL, O\u2019Flaherty E, Green M, Edmonds M, Nichol J, Menchaca DM et al (2002) Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99:2599\u20132602","journal-title":"Blood"},{"issue":"6","key":"3749_CR81","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB (2019) Thrombopoietin receptor agonists: ten years later. Haematologica 104(6):1112\u20131123","journal-title":"Haematologica"},{"issue":"7","key":"3749_CR82","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/bloodadvances.2016000844","volume":"1","author":"A Aihara","year":"2017","unstructured":"Aihara A, Koike T, Abe N, Nakamura S, Sawaguchi A, Nakamura T et al (2017) Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells. Blood Adv 1(7):468\u2013476","journal-title":"Blood Adv"},{"issue":"14","key":"3749_CR83","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2014-08-595561","volume":"125","author":"CA Di Buduo","year":"2015","unstructured":"Di Buduo CA, Wray LS, Tozzi L et al (2015) Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood 125(14):2254\u20132264","journal-title":"Blood"},{"key":"3749_CR84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm973","volume":"10","author":"ST Avecilla","year":"2004","unstructured":"Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10:64\u201371","journal-title":"Nat Med"},{"key":"3749_CR85","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2012-12-473884","volume":"122","author":"L Zhang","year":"2013","unstructured":"Zhang L, Urtz N, Gaertner F, Legate KR, Petzold T, Lorenz M, Mazharian A, Watson SP, Massberg S (2013) Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). Blood 122:791\u2013802","journal-title":"Blood"},{"key":"3749_CR86","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2015-05-644583","volume":"127","author":"KR Machlus","year":"2016","unstructured":"Machlus KR, Johnson KE, Kulenthirarajan R, Forward JA, Tippy MD, Soussou TS, El-Husayni SH, Wu SK, Wang S, Watnick RS, Italiano JE Jr, Battinelli EM (2016) CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood 127:921\u2013926","journal-title":"Blood"},{"key":"3749_CR87","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2012-03-416875","volume":"121","author":"IC Macaulay","year":"2013","unstructured":"Macaulay IC, Thon JN, Tijssen MR, Steele BM, MacDonald BT, Meade G, Burns P, Rendon A, Salunkhe V, Murphy RP, Bennett C, Watkins NA, He X, Fitzgerald DJ, Italiano JE Jr, Maguire PB (2013) Canonical Wnt signaling in megakaryocytes regulates proplatelet formation. Blood 121:188\u2013196","journal-title":"Blood"},{"issue":"1340\u20131352","key":"3749_CR88","first-page":"e1343","volume":"37","author":"LM Giammona","year":"2009","unstructured":"Giammona LM, Panuganti S, Kemper JM et al (2009) Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol 37(1340\u20131352):e1343","journal-title":"Exp Hematol"},{"issue":"10","key":"3749_CR89","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2004-10-3934","volume":"105","author":"BJ Lannutti","year":"2005","unstructured":"Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG (2005) Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 105(10):3875\u20133878","journal-title":"Blood"},{"issue":"2","key":"3749_CR90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13577-014-0102-2","volume":"28","author":"RW Nurhayati","year":"2015","unstructured":"Nurhayati RW, Ojima Y, Taya M (2015) BMS-777607 promotes megakaryocytic differentiation and induces polyploidization in the CHRF-288-11 cells. Hum Cell 28(2):65\u201372","journal-title":"Hum Cell"},{"issue":"10","key":"3749_CR91","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1182\/blood-2006-04-020024","volume":"109","author":"Y Chang","year":"2007","unstructured":"Chang Y, Aurad\u00e9 F, Larbret F, Zhang Y, Le Couedic JP, Momeux L, Larghero J, Bertoglio J, Louache F, Cramer E, Vainchenker W, Debili N (2007) Proplatelet formation is regulated by the Rho\/ROCK pathway. Blood 109(10):4229\u20134236","journal-title":"Blood"},{"key":"3749_CR92","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2008-03-144956","volume":"112","author":"L Lordier","year":"2008","unstructured":"Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N, Vainchenker W, Chang Y (2008) Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho\/Rock signaling. Blood 112:3164\u20133174","journal-title":"Blood"},{"key":"3749_CR93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjh.12709","volume":"164","author":"MP Avanzi","year":"2014","unstructured":"Avanzi MP, Goldberg F, Davila J, Langhi D, Chiattone C, Mitchell WB (2014) Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulation. Br J Haematol 164:867\u2013876","journal-title":"Br J Haematol"},{"key":"3749_CR94","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood-2013-04-490599","volume":"122","author":"G Gobbi","year":"2013","unstructured":"Gobbi G, Mirandola P, Carubbi C, Masselli E, Sykes SM, Ferraro F, Nouvenne A, Thon JN, Italiano JE Jr, Vitale M (2013) Proplatelet generation in the mouse requires PKC\u03b5-dependent RhoA inhibition. Blood 122:1305\u20131311","journal-title":"Blood"},{"issue":"28","key":"3749_CR95","doi-asserted-by":"crossref","first-page":"11458","DOI":"10.1073\/pnas.1017474108","volume":"108","author":"JW Shin","year":"2011","unstructured":"Shin JW, Swift J, Spinler KR, Discher DE (2011) Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci USA 108(28):11458\u201311463","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"3749_CR96","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/j.1537-2995.2012.03711.x","volume":"52","author":"MP Avanzi","year":"2012","unstructured":"Avanzi MP, Chen A, He W, Mitchell WB (2012) Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. Transfusion 52(11):2406\u20132413","journal-title":"Transfusion"},{"issue":"6","key":"3749_CR97","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/bloodadvances.2017010975","volume":"2","author":"D Jarocha","year":"2018","unstructured":"Jarocha D, Vo KK, Lyde RB, Hayes V, Camire RM, Poncz M (2018) Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors. Blood Adv 2(6):597\u2013606","journal-title":"Blood Adv"},{"key":"3749_CR98","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","volume":"329","author":"AE Boitano","year":"2010","unstructured":"Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, Schultz PG, Cooke MP (2010) Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329:1345\u20131348","journal-title":"Science"},{"key":"3749_CR99","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2012-11-466722","volume":"122","author":"BW Smith","year":"2013","unstructured":"Smith BW, Rozelle SS, Leung A, Ubellacker J, Parks A, Nah SK, French D, Gadue P, Monti S, Chui DH, Steinberg MH, Frelinger AL, Michelson AD, Theberge R, McComb ME, Costello CE, Kotton DN, Mostoslavsky G, Sherr DH, Murphy GJ (2013) The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood 122:376\u2013385","journal-title":"Blood"},{"key":"3749_CR100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","volume":"18","author":"JE Wagner Jr","year":"2016","unstructured":"Wagner JE Jr, Brunstein CG, Boitano AE, DeFor TE, McKenna D, Sumstad D, Blazar BR, Tolar J, Le C, Jones J, Cooke MP, Bleul CC (2016) Phase I\/II trial of stemregenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft. Cell Stem Cell 18:144\u2013155","journal-title":"Cell Stem Cell"},{"key":"3749_CR101","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1182\/blood-2015-09-670208","volume":"127","author":"C Strassel","year":"2016","unstructured":"Strassel C, Brouard N, Mallo L, Receveur N, Mangin P, Eckly A, Bieche I, Tarte K, Gachet C, Lanza F (2016) Aryl hydrocarbon receptor-dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets. Blood 127:2231\u20132240","journal-title":"Blood"},{"key":"3749_CR102","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.3150","volume":"19","author":"AJ Murphy","year":"2013","unstructured":"Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, Wang N (2013) Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 19:586\u2013594","journal-title":"Nat Med"},{"key":"3749_CR103","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood-2016-01-631259","volume":"127","author":"N Wang","year":"2016","unstructured":"Wang N, Tall AR (2016) Cholesterol in platelet biogenesis and activation. Blood 127:1949\u20131953","journal-title":"Blood"},{"issue":"1081\u20138","key":"3749_CR104","first-page":"10","volume":"17","author":"LC Lasky","year":"2011","unstructured":"Lasky LC, Sullenbarger B (2011) Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood. Tissue Eng Part C Methods 17(1081\u20138):10","journal-title":"Tissue Eng Part C Methods"},{"key":"3749_CR105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/scd.2007.0149","volume":"17","author":"N Pineault","year":"2008","unstructured":"Pineault N, Boucher JF, Cayer MP, Palmqvist L, Boyer L, Lemieux R, Proulx C (2008) Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev 17:483\u2013493","journal-title":"Stem Cells Dev"},{"issue":"17","key":"3749_CR106","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/bloodadvances.2018019547","volume":"2","author":"H Seo","year":"2018","unstructured":"Seo H, Chen SJ, Hashimoto K et al (2018) A \u03b21-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production. Blood Adv 2(17):2262\u20132272","journal-title":"Blood Adv"},{"key":"3749_CR107","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.0000143899.73453.11","volume":"95","author":"W Bergmeier","year":"2004","unstructured":"Bergmeier W, Piffath CL, Cheng G et al (2004) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 95:677\u2013683","journal-title":"Circ Res"},{"key":"3749_CR108","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1538-7836.2007.02590.x","volume":"5","author":"EE Gardiner","year":"2007","unstructured":"Gardiner EE, Karunakaran D, Shen Y et al (2007) Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 5:1530\u20131537","journal-title":"J Thromb Haemost"},{"key":"3749_CR109","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood-2009-03-213504","volume":"114","author":"B Dumont","year":"2009","unstructured":"Dumont B, Lasne D, Rothschild C et al (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114:1900\u20131903","journal-title":"Blood"},{"key":"3749_CR110","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1182\/blood-2003-04-1305","volume":"102","author":"W Bergmeier","year":"2003","unstructured":"Bergmeier W, Burger PC, Piffath CL et al (2003) Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro- aged or -injured mouse platelets. Blood 102:4229\u20134235","journal-title":"Blood"},{"key":"3749_CR111","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.20071482","volume":"205","author":"H Nishikii","year":"2008","unstructured":"Nishikii H, Eto K, Tamura N et al (2008) Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med 205:1917\u20131927","journal-title":"J Exp Med"},{"key":"3749_CR112","doi-asserted-by":"crossref","first-page":"720","DOI":"10.5966\/sctm.2016-0104","volume":"6","author":"S Hirata","year":"2016","unstructured":"Hirata S, Murata T, Suzuki D, Nakamura S, Jono-Ohnishi R, Hirose H et al (2016) Selective inhibition of ADAM17 efficiently mediates glycoprotein Ibalpha retention during ex vivo generation of human induced pluripotent stem cell-derived platelets. Stem Cells Transl Med. 6:720\u2013730","journal-title":"Stem Cells Transl Med."},{"issue":"9","key":"3749_CR113","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2009-03-209205","volume":"114","author":"C Dunois-Lard\u00e9","year":"2009","unstructured":"Dunois-Lard\u00e9 C, Capron C, Fichelson S, Bauer T, Cramer-Bord\u00e9 E, Baruch D (2009) Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114(9):1875\u20131883","journal-title":"Blood"},{"issue":"1","key":"3749_CR114","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.exphem.2008.09.009","volume":"37","author":"B Sullenbarger","year":"2009","unstructured":"Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC (2009) Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 37(1):101\u2013110","journal-title":"Exp Hematol"},{"issue":"8","key":"3749_CR115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.exphem.2013.04.007","volume":"41","author":"Y Nakagawa","year":"2013","unstructured":"Nakagawa Y, Nakamura S, Nakajima M, Endo H, Dohda T, Takayama N et al (2013) Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol 41(8):742\u2013748","journal-title":"Exp Hematol"},{"issue":"6","key":"3749_CR116","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/btpr.2563","volume":"33","author":"AF Martinez","year":"2017","unstructured":"Martinez AF, McMahon RD, Horner M, Miller WM (2017) A uniform-shear rate microfluidic bioreactor for real-time study of proplatelet formation and rapidly-released platelets. Biotechnol Prog 33(6):1614\u20131629","journal-title":"Biotechnol Prog"},{"key":"3749_CR117","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2014-05-574913","volume":"124","author":"JN Thon","year":"2014","unstructured":"Thon JN, Mazutis L, Wu S, Sylman JL, Ehrlicher A, Machlus KR, Feng Q, Lu S, Lanza R, Neeves KB, Weitz DA, Italiano JE Jr (2014) Platelet bioreactor-on-a-chip. Blood 124:1857\u20131867","journal-title":"Blood"},{"key":"3749_CR118","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2014-08-595561","volume":"125","author":"CA Di Buduo","year":"2015","unstructured":"Di Buduo CA, Wray LS, Tozzi L, Malara A, Chen Y, Ghezzi CE, Smoot D, Sfara C, Antonelli A, Spedden E, Bruni G, Staii C, De Marco L, Magnani M, Kaplan DL, Balduini A (2015) Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood 125:2254\u20132264","journal-title":"Blood"},{"key":"3749_CR119","doi-asserted-by":"crossref","first-page":"21700","DOI":"10.1038\/srep21700","volume":"6","author":"A Blin","year":"2016","unstructured":"Blin A, Le Goff A, Magniez A, Poirault-Chassac S, Teste B, Sicot G, Nguyen KA, Hamdi FS, Reyssat M, Baruch D (2016) Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics. Sci Rep 6:21700","journal-title":"Sci Rep"},{"key":"3749_CR120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/trf.13375","volume":"56","author":"MP Avanzi","year":"2016","unstructured":"Avanzi MP, Oluwadara OE, Cushing MM, Mitchell ML, Fischer S, Mitchell WB (2016) A novel bioreactor and culture method drives high yields of platelets from stem cells. Transfusion 56:170\u2013178","journal-title":"Transfusion"},{"issue":"4","key":"3749_CR121","doi-asserted-by":"crossref","first-page":"e0230507","DOI":"10.1371\/journal.pone.0230507","volume":"15","author":"S Fujiyama","year":"2020","unstructured":"Fujiyama S, Hori N, Sato T, Enosawa S, Murata M, Kobayashi E (2020) Development of an ex vivo xenogeneic bone environment producing human platelet-like cells. PLoS ONE 15(4):e0230507","journal-title":"PLoS ONE"},{"key":"3749_CR122","doi-asserted-by":"crossref","first-page":"e54941","DOI":"10.1371\/journal.pone.0054941","volume":"8","author":"J Xi","year":"2013","unstructured":"Xi J, Zhu H, Liu D, Nan X, Zheng W, Liu K, Shi W, Chen L, Lv Y, Yan F, Li Y, Xie X, Wang Y, Yue W, Xu X, Wei X, Zhu J, Huang X, Pei X (2013) Infusion of megakaryocytic progenitor products generated from cord blood hematopoietic stem\/progenitor cells: results of the phase 1 study. PLoS ONE 8:e54941","journal-title":"PLoS ONE"},{"key":"3749_CR123","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2014-08-593053","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Hayes V, Jarocha D, Sim X, Harper DC, Fuentes R, Sullivan SK, Gadue P, Chou ST, Torok-Storb BJ, Marks MS, French DL, Poncz M (2015) Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale. Blood 125:3627\u20133636","journal-title":"Blood"},{"issue":"4","key":"3749_CR124","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/bit.25477","volume":"112","author":"AC Schlinker","year":"2015","unstructured":"Schlinker AC, Radwanski K, Wegener C, Min K, Miller WM (2015) Separation of in-vitro-derived megakaryocytes and platelets using spinning-membrane filtration. Biotechnol Bioeng 112(4):788\u2013800","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"3749_CR125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.transci.2015.05.002","volume":"53","author":"S Oikawa","year":"2015","unstructured":"Oikawa S, Taguchi T, Endo K, Hoshi T, Kawashima W, Horibe Y et al (2015) Storage of washed platelets in BRS-A platelet additive solutions based on two types of clinically available bicarbonated Ringer\u2019s solutions with different electrolyte concentrations. Transfus Apheres Sci 53(2):233\u2013237","journal-title":"Transfus Apheres Sci"},{"issue":"6","key":"3749_CR126","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOH.0000000000000456","volume":"25","author":"S Hegde","year":"2018","unstructured":"Hegde S, Akbar H, Zheng Y, Cancelas JA (2018) Towards increasing shelf life and haemostatic potency of stored platelet concentrates. Curr Opin Hematol 25(6):500\u2013508","journal-title":"Curr Opin Hematol"},{"issue":"7653","key":"3749_CR127","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","volume":"545","author":"FT Merkle","year":"2017","unstructured":"Merkle FT, Ghosh S, Kamitaki N et al (2017) Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature 545(7653):229\u2013233","journal-title":"Nature"},{"issue":"12","key":"3749_CR128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/sctm.18-0087","volume":"7","author":"L Rohani","year":"2018","unstructured":"Rohani L, Johnson AA, Naghsh P, Rancourt DE, Ulrich H, Holland H (2018) Concise review: molecular cytogenetics and quality control: clinical guardians for pluripotent stem cells. Stem Cells Transl Med 7(12):867\u2013875","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"3749_CR129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2010.08444.x","volume":"152","author":"J Treleaven","year":"2011","unstructured":"Treleaven J, Gennery A, Marsh J, Norfolk D, Page L, Parker A et al (2011) Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haematol 152(1):35\u201351","journal-title":"Br J Haematol"},{"issue":"3","key":"3749_CR130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1423-0410.2005.00618.x","volume":"88","author":"R Cardigan","year":"2005","unstructured":"Cardigan R, Turner C, Harrison P (2005) Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 88(3):153\u2013163","journal-title":"Vox Sang"},{"issue":"12","key":"3749_CR131","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1111\/trf.15559","volume":"59","author":"G Escolar","year":"2019","unstructured":"Escolar G, McCullough J (2019) Platelet in vitro assays: their correspondence with their in vivo hemostatic potential. Transfusion 59(12):3783\u20133793","journal-title":"Transfusion"},{"issue":"5","key":"3749_CR132","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","volume":"66","author":"SR Hanson","year":"1985","unstructured":"Hanson SR, Slichter SJ (1985) Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 66(5):1105\u20131109","journal-title":"Blood"},{"issue":"Suppl 1","key":"3749_CR133","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1538-7836.2007.02466.x","volume":"5","author":"PJ Newman","year":"2007","unstructured":"Newman PJ, Aster R, Boylan B (2007) Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. J Thromb Haemost 5(Suppl 1):305\u2013309","journal-title":"J Thromb Haemost"},{"key":"3749_CR134","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15953","author":"MP Gelderman","year":"2020","unstructured":"Gelderman MP, Cheng C, Xu F, Skripchenko A, Ryan J, Li Y, Whitley P, Wagner SJ, Vostal JG (2020) Validation of a SCID mouse model for transfusion by concurrent comparison of circulation kinetics of human platelets, stored under various temperature conditions, between human volunteers and mice. Transfusion. https:\/\/doi.org\/10.1111\/trf.15953 (Epub ahead of print)","journal-title":"Transfusion."},{"key":"3749_CR135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/tm.1997.0110095","volume":"11","author":"MA Blajchman","year":"1997","unstructured":"Blajchman MA, Lee DH (1997) The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfus Med Rev 11:95\u2013105","journal-title":"Transfus Med Rev"},{"key":"3749_CR136","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1537-2995.1998.38698326334.x","volume":"38","author":"SW Rothwell","year":"1998","unstructured":"Rothwell SW, Maglasang P, Krishnamurti C (1998) Survival of fresh human platelets in a rabbit model as traced by flow cytometry. Transfusion 38:550\u2013556","journal-title":"Transfusion"},{"issue":"8","key":"3749_CR137","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/trf.14189","volume":"57","author":"N Watanabe","year":"2017","unstructured":"Watanabe N, Nogawa M, Ishiguro M et al (2017) Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models. Transfusion 57(8):2035\u20132044","journal-title":"Transfusion"},{"issue":"3","key":"3749_CR138","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/blood.V82.3.993.993","volume":"82","author":"K Ogasawara","year":"1993","unstructured":"Ogasawara K, Ueki J, Takenaka M, Furihata K (1993) Study on the expression of ABH antigens on platelets. Blood 82(3):993\u2013999","journal-title":"Blood"},{"issue":"6","key":"3749_CR139","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MOH.0b013e328358b135","volume":"19","author":"NM Dunbar","year":"2012","unstructured":"Dunbar NM, Ornstein DL, Dumont LJ (2012) ABO incompatible platelets: risks versus benefit. Curr Opin Hematol 19(6):475\u2013479","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"3749_CR140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13639","volume":"171","author":"BR Curtis","year":"2015","unstructured":"Curtis BR (2015) Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia. Br J Haematol 171(5):671\u2013682","journal-title":"Br J Haematol"},{"key":"3749_CR141","unstructured":"jRCTa050190117; Clinical study of autologous transfusion of iPS cell-derived platelets for thrombocytopenia (iPLAT1) https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCTa050190117 (Accessed on September 6, 2020.)"},{"issue":"2","key":"3749_CR142","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12185-018-02565-y","volume":"109","author":"A Akabayashi","year":"2019","unstructured":"Akabayashi A, Nakazawa E, Jecker NS (2019) The world\u2019s first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells. Int J Hematol 109(2):239\u2013240","journal-title":"Int J Hematol"},{"key":"3749_CR143","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","volume":"13","author":"M Turner","year":"2013","unstructured":"Turner M, Leslie S, Martin NG, Peschanski M, Rao M, Taylor CJ, Trounson A, Turner D, Yamanaka S, Wilmut I (2013) Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 13:382\u2013384","journal-title":"Cell Stem Cell"},{"issue":"39","key":"3749_CR144","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-019-0106-0","volume":"2","author":"M Umekage","year":"2019","unstructured":"Umekage M, Sato Y, Takasu N (2019) Overview: an iPS cell stock at CiRA. Inflamm Regen 2(39):17","journal-title":"Inflamm Regen"},{"key":"3749_CR145","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1089\/hum.2013.074","volume":"24","author":"C Gras","year":"2013","unstructured":"Gras C, Schulze K, Goudeva L, Guzman CA, Blasczyk R, Figueiredo C (2013) HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model. Hum Gene Ther 24:1018\u20131028","journal-title":"Hum Gene Ther"},{"key":"3749_CR146","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2119\/molmed.2015.00235","volume":"22","author":"AK Borger","year":"2016","unstructured":"Borger AK, Eicke D, Wolf C, Gras C, Aufderbeck S, Schulze K et al (2016) Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions. Mol Med 22:274\u2013285","journal-title":"Mol Med"},{"issue":"1","key":"3749_CR147","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.stemcr.2019.11.011","volume":"14","author":"D Suzuki","year":"2020","unstructured":"Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, Akasaka M, Nakamura S, Higashi N, Xu H, Matsumoto T, Fujio K, Manz MG, Hotta A, Takizawa H, Eto K, Sugimoto N (2020) iPSC-derived platelets depleted of HLA class I are inert to anti-HLA class I and natural killer cell immunity. Stem Cell Rep 14(1):49\u201359","journal-title":"Stem Cell Rep"},{"key":"3749_CR148","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1038\/s41598-020-65577-x","volume":"10","author":"P Norbnop","year":"2020","unstructured":"Norbnop P, Ingrungruanglert P, Israsena N et al (2020) Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells. Sci Rep 10:8472","journal-title":"Sci Rep"},{"key":"3749_CR149","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1537-2995.2002.00051.x","volume":"42","author":"S Saito","year":"2002","unstructured":"Saito S, Ota S, Seshimo H, Yamazaki Y, Nomura S, Ito T, Miki J, Ota M, Fukushima H, Maeda H (2002) Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens. Transfusion 42:302\u2013308","journal-title":"Transfusion"},{"key":"3749_CR150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495\u2013502","journal-title":"Nat Immunol"},{"key":"3749_CR151","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","volume":"31","author":"EO Long","year":"2013","unstructured":"Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31:227\u2013258","journal-title":"Annu Rev Immunol"},{"key":"3749_CR152","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse GG, Hirata RK, Funk SE, Riolobos L, Lopes VS, Manske G, Prunkard D, Colunga AG, Hanafi L-A, Clegg DO, Turtle C, Russell DW (2017) HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol 35:765\u2013772","journal-title":"Nat Biotechnol"},{"key":"3749_CR153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stem.2018.12.010","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A (2019) Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24:1\u201313","journal-title":"Cell Stem Cell"},{"issue":"6","key":"3749_CR154","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2015-10-675751","volume":"127","author":"N Zhang","year":"2015","unstructured":"Zhang N, Zhi H, Curtis BR, Rao S, Jobaliya C, Poncz M et al (2015) CRISPR\/Cas9-mediated conversion of human platelet alloantigen allotypes. Blood 127(6):675\u2013680","journal-title":"Blood"},{"issue":"5978","key":"3749_CR155","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1126\/science.328.5978.562","volume":"328","author":"M Leslie","year":"2010","unstructured":"Leslie M (2010) Cell biology. Beyond clotting: the powers of platelets. Science 328(5978):562\u2013564","journal-title":"Science"},{"issue":"2","key":"3749_CR156","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/term.2785","volume":"13","author":"N Zhang","year":"2019","unstructured":"Zhang N, Newman PJ (2019) Packaging functionally important plasma proteins into the \u03b1-granules of human-induced pluripotent stem cell-derived megakaryocytes. J Tissue Eng Regen Med 13(2):244\u2013252","journal-title":"J Tissue Eng Regen Med"},{"issue":"18","key":"3749_CR157","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/bloodadvances.2019000516","volume":"3","author":"C Gao","year":"2019","unstructured":"Gao C, Schroeder JA, Xue F et al (2019) Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Adv 3(18):2700\u20132711","journal-title":"Blood Adv"},{"key":"3749_CR158","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/ncomms3773","volume":"4","author":"LM Du","year":"2013","unstructured":"Du LM, Nurden P, Nurden AT, Nichols TC, Bellinger DA, Jensen ES, Haberichter SL, Merricks E, Raymer RA, Fang J, Koukouritaki SB, Jacobi PM, Hawkins TB, Cornetta K, Shi Q, Wilcox DA (2013) Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nat Commun 4:2773","journal-title":"Nat Commun"},{"issue":"9","key":"3749_CR159","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1021\/acs.nanolett.8b02321","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang J, Chen Z et al (2018) Engineering PD-1-presenting platelets for cancer immunotherapy. Nano Lett 18(9):5716\u20135725","journal-title":"Nano Lett"},{"issue":"11","key":"3749_CR160","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1039\/C9BM01026B","volume":"7","author":"P Xu","year":"2019","unstructured":"Xu P, Jiang Y, Zuo H et al (2019) Vincristine-loaded platelets coated with anti-CD41 mAbs: a new macrophage targeting proposal for the treatment of immune thrombocytopenia. Biomater Sci 7(11):4568\u20134577","journal-title":"Biomater Sci"},{"issue":"12","key":"3749_CR161","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/mt.2014.128","volume":"22","author":"T Nishikawa","year":"2014","unstructured":"Nishikawa T, Tung LY, Kaneda Y (2014) Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice. Mol Ther 22(12):2046\u20132055","journal-title":"Mol Ther"},{"key":"3749_CR162","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2147\/OTT.S104691","volume":"9","author":"P Xu","year":"2016","unstructured":"Xu P, Wang R, Wang X, Ouyang J (2016) Recent advancements in erythrocytes, platelets, and albumin as delivery systems. Onco Targets Ther 9:2873\u20132884","journal-title":"Onco Targets Ther"},{"issue":"10","key":"3749_CR163","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood-2015-07-607937","volume":"127","author":"DA Wilcox","year":"2016","unstructured":"Wilcox DA (2016) Megakaryocyte- and megakaryocyte precursor-related gene therapies. Blood 127(10):1260\u20131268","journal-title":"Blood"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-020-03749-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T07:08:08Z","timestamp":1618124888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-020-03749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":163,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3749"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03749-8","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"10 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}